Vimarsana
Biggest News Aggregation in the World

Page 6 - Scott Struthers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Scott Struthers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Scott Struthers Today - Breaking & Trending Today

Oppenheimer Boosts Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $46.00 - Vimarsana News

Oppenheimer Boosts Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $46.00

Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) had its price target upped by Oppenheimer from $40.00 to $46.00 in a report released on Monday morning, Marketbeat reports. The firm currently has an outperform rating on the stock. Other research analysts also recently issued reports about the company. HC Wainwright reissued a buy rating and issued a […]

Crinetics Pharmaceuticals (NASDAQ:CRNX) Shares Gap Up After Analyst Upgrade - Vimarsana News

Crinetics Pharmaceuticals (NASDAQ:CRNX) Shares Gap Up After Analyst Upgrade

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report)’s share price gapped up before the market opened on Tuesday after Evercore ISI raised their price target on the stock from $41.00 to $48.00. The stock had previously closed at $26.08, but opened at $27.00. Evercore ISI currently has an outperform rating on the stock. Crinetics Pharmaceuticals […]

Source: wkrb13.com
Investors Purchase High Volume of Put Options on Crinetics Pharmaceuticals (NASDAQ:CRNX) - Vimarsana News

Investors Purchase High Volume of Put Options on Crinetics Pharmaceuticals (NASDAQ:CRNX)

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw some unusual options trading activity on Tuesday. Stock traders bought 2,787 put options on the company. This represents an increase of 269% compared to the typical volume of 756 put options. Insider Activity In other news, CFO Marc Wilson sold 30,922 shares of the firm’s stock […]

Source: wkrb13.com
Crinetics scores phase 3 win with oral treatment for acromegaly - Vimarsana News

Crinetics scores phase 3 win with oral treatment for acromegaly

An oral treatment, developed by the U.S. company Crinetics Pharmaceuticals, Inc., has shown promise as an alternative to injected therapies for tackling the rare disease acromegaly in a phase 3 trial.

Robert W. Baird Raises Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $45.00 - Vimarsana News

Robert W. Baird Raises Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $45.00

Crinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report) had its price target lifted by analysts at Robert W. Baird from $43.00 to $45.00 in a note issued to investors on Monday, FlyOnTheWall reports. Robert W. Baird’s target price points to a potential upside of 181.78% from the stock’s current price. A number of other analysts also […]